fexofenadine has been researched along with Bright Disease in 1 studies
fexofenadine: a second generation antihistamine; metabolite of the antihistaminic drug terfenadine; structure in first source; RN refers to HCl
fexofenadine : A piperidine-based anti-histamine compound.
Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Joy, MS | 1 |
| Frye, RF | 1 |
| Nolin, TD | 1 |
| Roberts, BV | 1 |
| La, MK | 1 |
| Wang, J | 1 |
| Brouwer, KL | 1 |
| Dooley, MA | 1 |
| Falk, RJ | 1 |
1 trial available for fexofenadine and Bright Disease
| Article | Year |
|---|---|
In vivo alterations in drug metabolism and transport pathways in patients with chronic kidney diseases.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Breath Tests; Case-Control Studies; Cytochrome | 2014 |